Eye research paves way for more successful cornea transplants

July 6, 2012

(Medical Xpress) -- Scientists at the University of Reading have made a significant breakthrough in cornea transplant research that could make future procedures more successful.

Amniotic membrane (AM) has been used in the clinical treatment of eye disorders for over a decade. During this time it has been seen as an excellent natural surface on which to grow corneal stem cells, despite the fact that its structural and biological properties have been poorly understood.

Furthermore, regardless of AM's many reported successful ophthalmic outcomes, the resulting clinical efficacy has lacked predictability - its success rate, when used in conjunction with stem cells, ranges from 46% to 100%.

Researchers from Reading have now shown that the location of the AM, relative to the placenta, plays a crucial part in its success as a . AM taken nearer to the placenta is stiffer than that taken from further away, and this difference in mechanical properties dramatically effects the functionality of the stem cells. This is particularly pertinent as the underlying clinical reason for using AM is that the transplanted cells should remain in a relatively unchanged state to maximize their clinical effect.

Dr Che Connon, from Reading School of Pharmacy, said: "Our work suggests that clinical results could be improved by using AM collected from an area close to the placenta, or by normalizing the substrate's (stiffness), chemically, prior to use.

"Until now no consideration has been given to the origin of the AM, relative to the , when used as a surface for the expansion of prior to transplantation. Our new research should improve the success of the procedure."

Explore further: Engineered cornea more resistant to chemical injury

More information: The paper, The mechanical properties of amniotic membrane influence its effect as a biomaterial for ocular surface repair, by Bo Chen, Roanne R. Jones, Shengli Mi, James Foster, Simon G. Alcock, Ian W. Hamley and Che J. Connon, appears in Soft Matter, DOI:10.1039/C2SM26175H

Related Stories

Engineered cornea more resistant to chemical injury

May 28, 2012
(Medical Xpress) -- A new study from the University of Reading has established that a prosthetic cornea made from human cells is the best model for testing how irritants and toxins cause eye injuries.

Stem cell research could prevent premature births

September 7, 2011
Researchers from the University of Reading have developed the first fully tissue-engineered fetal membrane from human stem cells that could significantly reduce the number of premature births.

Two patients in Scotland get stem cell transplants to treat blindness

May 22, 2012
(Medical Xpress) -- Two people in Scotland have received stem cell transplants into their eyes in a clinical trial that is aimed at restoring vision in people that suffer some degree of blindness due to damage to the cornea. ...

Recommended for you

World's blind population to soar: study

August 3, 2017
The world's blind will increase threefold from about 36 million today to 115 million in 2050 as populations expand and individuals grow ever older, researchers said Thursday.

Simulations signal early success for fractal-based retinal implants

July 27, 2017
Computer simulations of electrical charges sent to retinal implants based on fractal geometry have University of Oregon researchers moving forward with their eyes focused on biological testing.

Scientists regenerate retinal cells in mice

July 26, 2017
Scientists have successfully regenerated cells in the retina of adult mice at the University of Washington School of Medicine in Seattle.

Genome editing with CRISPR-Cas9 prevents angiogenesis of the retina

July 24, 2017
A research team from the Schepens Eye Research Institute of Massachusetts Eye and Ear has successfully prevented mice from developing angiogenesis of the retina—the sensory tissue at the back of the eye—using gene-editing ...

Too little vitamin D may hinder recovery of injured corneas

July 24, 2017
Injury or disease in combination with too little vitamin D can be bad for the window to your eyes.

Combination of type 2 diabetes and sleep apnoea indicates eyesight loss within four years

July 4, 2017
Research led by the University of Birmingham has discovered that patients who suffer from both Type 2 diabetes and obstructive sleep apnoea are at greater risk of developing a condition that leads to blindness within an average ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.